(MedPage Today) — PHOENIX — A migraine medication targeting calcitonin gene-related peptide (CGRP) pathways wasn’t shown to improve daily abdominal pain scores in irritable bowel syndrome (IBS), but it may help reduce gut pain sensitivity…
Source link : https://www.medpagetoday.com/meetingcoverage/acg/118234
Author :
Publish date : 2025-10-30 17:34:00
Copyright for syndicated content belongs to the linked Source.
